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1. Introduction 
Semliki Forest Virus causes shut-off of protein syn- 
thesis in its mammalian hosts [ 1,2]. Usually, this shut- 
off takes place 3-5 h post-infection [2]. In neuro- 
blastoma cells from mouse such an event leads to the 
exclusive production of late viral (= structural) pro- 
teins (e.g., ~97, ~62, El and capsid protein, see [2--41). 
These proteins are synthehized as a large precursor 
from a sub-genomic template of 26 S [ 1 ,.S] an mRNA 
which appears late in infection and is identical to the 
3’-terminal part (-1/3rd) of the viral genomic RNA 
of 42 S [6,7]. This 42 S mRNA serves as a template 
early in infection for the synthesis of non-structural 
proteins [2,4]. The genes for these proteins are located 
at the 5’-terminus of this messenger, whereas the genes 
for the structural proteins, which are found at the 
3’-part of 42 S are silent (see above, [2]). At a late 
stage of infection, 26 S mRNA is the only messenger 
recognized by the protein synthesizing machinery, 
despite of the fact that still considerable amounts of 
42 S and host mRNAs are present in the infected cell 
[1,%31. 
High salt washes of ribosomes (containing the initia- 
tion factors of protein synthesis), isolated from neuro- 
blastoma cells at a late stage of infection by SFV, have 
mostly lost the ability to support the trsnslation in 
‘in vitro’ systems of host- and early viral mRNA, 
although they are still highly active with viral late- 
and EMC mRNA [9]. 
Addition to systems programmed with host- and 
viral early mRNA, of purified initiation factors eIF4B 
(M, 80 000, [9,10]) and cap binding protein (CBP, 
MI 24 000, [9,1 l]), but none of the others signifi- 
cantly increases the activity of these infectionexposed 
crude initiation factors. 
These fmdings indicate that the lesion in the pro- 
tein synthesizing machinery has occurred at the level 
of initiation factors eIF4B and CBP, although the 
precise mechanism by which these factors are incapac- 
itated remains, at present, unclear. 
Here we substantiate the ability of purified eIF4B 
and CBP to stimulate the activity of infectionexposed 
crude factors in protein synthesis in an ‘in vitro’ system 
programmed with early viral mRNA. We explore why 
the SFV-induced blockade of eIF4B and CBP activity 
results in a preferential recognition of late SFV mRNA 
by the protein synthesizing machinery in infected cells. 
We show that optimal translation of 26 S mRNA 
requires a 2-4-times smaller amount of eIF4B and 
CBP when compared to host- and 42 S mRNA. Such 
a low requirement for eIF4B and CBP results in a 
relatively undisturbed translation of viral late mRNA 
in infected cells in spite of the fact that these factors 
are gradually inactivated. The reason for the decreased 
need for eIF4B and CBP, factors which are thought 
to be involved in the recognition of the 5’-terminal 
cap structure of mRNAs [ 12-141 is not based on a 
decreased importance of the cap-structure of 26 S 
mRNA, since chemically decapped 26 S RNA almost 
completely looses its capacity to serve as a template 
in pH 5 systems. 
2. Materials and methods 
2.1. Materials 
The following components were prepared by the 
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methods in [9,10,15-171: pH 5 enzymes, crude ini- 
tiation factors from control- and SFV-infected neuro- 
blastoma cells, ribosomal subunits from rat liver, 42 S 
and 26 S SFV RNS, neuroblastoma poly(A) RNA 
(host mRNA) and purified initiation factors from rab- 
bit reticulocytes. EMC virus was grown on neuroblast- 
oma cells;purification of the virions was obtained using 
standard techniques, which have been described for 
SFV isolation [ 151. The EMC RNA was freed from 
proteins by extraction of the virions with a phenol/ 
chloroform mixture (1: 1) in 0.5% lithiumdodecylsul- 
phate, thereafter the RNA was precipitated with 
ethanol and dissolved in H20 at 2 mg/ml. 
2.2. Assays 
2.2.1. pH 5 sytem 
Protein synthesis was determined in reconstituted 
pH 5 systems of 10 /..d with crude initiation factors of 
protein synthesis (8 pg fraction A and 12 l.(g fraction 
BC, see [9,18]) from SFV-infected or control neuro- 
blastoma cells. The composition of this translation 
assay system has been described in [9]. lncorpora- 
tion of [3sS]methionine into protein was measured 
as described after 45 min incubation at 37°C in 5 ~1 
aliquots [9]. 
2.2.2. Restoring assay 
As shown in [9] crude initiation factors of protein 
synthesis from SFV-infected neuroblastoma cells are 
unable to support protein synthesis with SFV 42 S 
mRNA as a template,unless supplemented with eIF-4B 
and CBP. In this assay we measured the ability of vari- 
ous amounts of eIF4B and CBP as indicated to stim- 
ulate protein synthesis with infectionexposed crude 
initiation factors and 42 S SFV mRNA as a template. 
Incorporation of [35S]methionine into protein was 
measured as in section 2.2.1. 
2.2.3. eIF4B and CBP assay 
This assay was used to determine the requirement 
for eIF4B and CBP to obtain optimal translation in a 
pH 5 system [9,18]. The incubation mixture of 10 ~1 
contained: HEPES/KOH, ATP, GTP, creatine phos- 
phate, dithiothreitol, creatine kinase, ribosomes, tRNA 
and pH 5 enzymes as in [9]. Further additions were: 
12 pg fraction BC [ 181 of non-infected neuroblastoma 
cells, mRNA as indicated in fig.2 and 1.4 l.(g high-salt 
treated eIF-3 (12) and, for CBP assay 2 pg eIF4B 
and, for eIF4B assay 2 pg CBP. Incorporation of 
[35S]methionine was measured as above. 
2.3. Quantification of the 5’ cap structure on late 
polysomal26 S mRNA and viral 42 S mRNA 
2.3 .l . Labeling of mRNAs 
Mouse neuroblastoma cells were grown and infected 
with wild-type SFV as in [ 151. At 1 h post-infection 
the inoculum (25 ml) was replaced by 50 ml phosphate- 
free minimal essential medium, supplemented with 
3% fetal calf serum and 1 pg actinomycin D/ml. At 
3 h post-infection 10 mCi carrier-free [32P]orthophos- 
phate was added. For the labeling of polysomal mRNA 
100 pg cycloheximide/ml was added to the medium 
at 8 h post-infection. After 15 min the cells were 
washed twice with phosphate-buffered saline (sup- 
plemented with 1 pg cyclohexiymide/ml. Cell lysis 
and further purification of late polysoma126 S mRNA 
has been described in [9]. 
For the preparation of [32P] viral 42 S mRNAlabel- 
ing was continued up to 18 h post-infection. 42 S RNA 
was isolated from the virions as in [ 151.26 S and 42 S 
mRNA were precipitated twice with ethanol and the 
total [32P]orthophosphate incorporation was deter- 
mined by counting the Cerenkov radiation. 
2.3.2. Quantification of the 5’ cap-structures of 26 S 
and 42 S mRNA 
The 32P-labeled mRNAs were incubated with RNase 
Tr (10 pg), RNase T2 (3 U) and RNase A (20 pg) in 
10 mM Tris-HCl (pH 7.5) and 1 mM EDTA for 2 h 
at 37°C. The products of digestion were separated on 
a standard two-dimensional system in [19]. The loca- 
tion of the nucleotide monophosphates and the ‘cap’ 
was determined by autoradiography and the absolute 
amounts of the cap-product were measured by cutting 
out the spot and counting the Cerenkov radiation. 
2.4. Decapping of mRNAs 
Late polysoma126 S and viral 42 S mRNA were 
chemically decapped as in [20]. Under these condi- 
tions no internal breaks are introduced in the mRNAs 
as was determined on agarose gels under denaturating 
conditions. Of the 5’ terminal cap >80% is removed 
following section 2.3 (not shown). As control messen- 
gers we subjected to the same decapping procedure 
globin 9 S mRNA and EMC mRNAs which does not 
contain a 2’,3’-dihydroxyribose at its S’end and there- 
fore should not be affected by the procedure. 
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3. Results and discussion 
3.1. Restoring the activity of infection-exposed initia- 
tion factors 
Crude initiation factors of protein synthesis, iso- 
lated from Semliki Forest virus (SFV)-infected neuro- 
blastoma cells show a pronounced loss of activity 
(<90%) when tested in pH 5 systems with host- or 
early SFV mRNA (42 S) as a template (see Introduc- 
tion in [9]). Protein synthesis with late SFV (26 S)- 
or EMC mRNA, however proceeds relatively undis- 
turbed in the presence of this fraction [9]. In a pre- 
liminary experiment, we showed that purified initia- 
tion factors eIF-4B and CBP from rabbit reticulocytes 
stimulated the translation of 42 S and host-mRNA 
with infection exposed washes [9]. The dependence 
of eIF4B and CBP of the translation of viral early 
42 S RNA by infectionexposed crude initiation fac- 
tors in pH 5 systems (restoring assay) is shown in 
fig.1. It is clear that eIF4B alone (fig.1, left and right 
panel) is able to restore the activity of these washes 
<70% as compared to control washes. Addition of 
saturating amounts of CBP restores -50% of the trans- 
lational capacity of the infectionexposed washes, in 
Fig.1, Restoring the activity of infectionexposed initiation 
factors. Amounts of eIF4B (as indicated) were added to pH 
5 systems (10 ~1) with crude initiation factors from control 
(o-o) and SFV-infected (o-e) neuroblastoma ceils and 42 S 
mRNA (1 pg) as a template, both in the absence (left) and 
presence (middle) of 2 pg CBP. The relative restoring activity 
as compared to control incubations (II and IV, = 100%) of 
eIF4B (m-m) and eIF4B plus CBP (4-4) is shown on the right. 
[?S]Methionine incorporation into protein was measured in 
5 ~1 aliquots. 
which case addition of eIF4B results in further stim- 
ulation <90%. 
These results are consistent with previous findings 
and indicate that eIF-4B and CBPcooperate in restoring 
the activity of SFV-exposed ribosomal washes. It 
should be pointed out that these factors, although 
similar in action, are different entities which is demon- 
strated by the fact that large amounts of CBP do not 
stimulate in an assay system for eIF4B (or vice versa; 
see [9]). 
3.2. Requirement for eIF-4B and CBP of different 
mRNAs in pH 5 systems 
The observation that the translation of late SFV 
and EMC mRNA was not affected by the transition 
from control to viral exposed initiation factors together 
with the results of fig.1 evoked the important question 
whether the utilization as a template of these mRNAs 
is eIF4B and CPBindependent. Therefore, we set UP 
an experiment in which we compared the requirement 
for eIF4B and CBP to achieve optimal translation with 
host-, EMC-, viral early (42 S)- and late (26 S) mRNA 
(fig.2). It is striking that optimal protein synthesis with 
Fig.2. Determination of eIF4B and CBP requirement to 
obtain optimal translation of different mRNAs. Increasing 
amounts of eIF4B (left) and CBP (right) as indicated in the 
figure were added to the assay systems for eIF4B and CBP 
(see section 2) to determine at which quantity of each factor 
added, optimal translation of different mRNAs is obtained. 
The assay systems were programmed with: 0.8 c(g EMC-RNA 
(A-A); 1 pg 26 S RNA (e-e); 1 pg42 S RNA (~-a) or 0.9 ng 
host mRNA (o-o). Percentages of incorporation relative to 
the value obtained at maximal translation of each mRNA are 
shown as a function of initiation factor added. The maximal 
incorporation of [3sS]methionine into protein (in cpm) in 
the eIF4B assay are: 86 000; 50 000; 54 500; 41 000 in the 
case of added 42 S, EMC-, 26 S or host rnRNA, respectively. 
In the CBP assay these values are: 181 000; 52 000; 54 000; 
125 000. 
64 
Volume 129, number 1 FEBS LETTERS June 1981 
Fig.3. Determination of the molar ratio of the cap structure 
and 26 S or 42 S mRNA. The molar ratio of cap and mRNA 
was determined (top) by counting the total radioactivity 
incorporated in the mRNAs (see section 2) and in the cap 
containing spots originated from 42 S mRNA (bottom (I)) 
and 26 S mRNA (bottom (II)). The total digests were separated 
on a two-dimensional system, [ 191 and the position of each 
product was located by autoradiography (see bottom). 
Quantification of the cap structure of 42 S and 26 S mRNA. 
mRNA 
1.42s 
II. 26 S 
Total =P 
inc. (cpm) 
392 000 
559 200 
Total ‘*Pin 
‘cap’ (cpm) 
125 
384 
Ratio 
(cap/mRNA) 
1.0 
1.0 
SFV early and host mRNA requires 2-4-times the 
amount of eIF4B than translation of SFV-late and 
EMC mRNA (see fig.2, left). 
A similar observation was obtained in the determina- 
tion of the CBP requirement for optimal translation 
with the different mRNAs (fig.2, right). In this assay 
smaller amounts of CBP are needed with late SFV and 
EMC mRNA than with 42 S early- and host mRNA. 
As a control experiment we determined the require- 
ment in protein synthesis for other initiation factors 
such as eIF-2 and eIF-3. We observed an equal need 
for these factors with different mRNAs (not shown). 
It is clear, therefore, that the translation of viral 
late mRNA requires a considerably smaller amount 
of eIF-4B and CBP than that of host and viral early 
mRNA. This observation provides an explanation for 
the fact that infectionexposed washes in which CBP 
and eIF4B are partially inactivated are still fully capa- 
ble of supporting translation of late SFV mRNA. 
3.3.26 S polysomal mRNA is fully capped 
CBP and eIF4B are initiation factors which are 
thought to be involved in the recognition of the .5’- 
terminal cap-structure present on most eukaryotic 
mRNAs [ 12-141. Although EMC RNA is uncapped 
and carries covalently linked to its 5’-end a protein 
which is not involved in protein synthesis [2 11, this 
Table 1 
The effect of chemical decapping on the translation of differ- 
ent mRNAs in pH 5 systems 
mRNA Incorporation (cpm X lo-“) 
- 
26 S 
42 S 
Globin 9 S 
EMC 
Non-treated Treated B/A 
(A) @I x 100% 
105 20 19 
172 115 67 
123 91 74 
67 75 112 
EMC-, 26 S, 42 S and globin 9 S mRNA were subjected to a 
decapping procedure [20] and the effect on the ability to act 
as a template in pH 5 systems (10 rl) was determined (B). 
The non-treated mRNAs were translated in control pH 5 sys- 
tems (A). The systems were programmed with 1 pg globin 9 S 
or with amounts of the other mRNAs, as indicated in the leg- 
end to fii.2. [ 35S]Methionine incorporation into protein was 
determined in 5 ~1 aliquots as in [9]. 
mRNA also needs a small amount of eIF4B and CBP 
for optimal translation (fig.2, [ 131). 
26 S late mRNA is almost equally dependent on 
eIF4B and CBP for its translation as EMC-RNA, sug- 
gesting that the 26 S mRNA is uncapped also. Never- 
theless, cellular 26 S RNA is capped, but a precise 
quantification is lacking [22]. In view of these obser- 
vations it seemed of interest to determine to what 
extent actively translated 26 S mRNA, present in 
polysomes late in infection, is capped. Therefore, we 
purified both 26 Sand 42 S mRNA (uniformly labeled 
with [32P]orthophosphate) from SFV-infected neuro- 
blastoma cells and SFV virions, respectively (section 2). 
RNase digestion of the messengers and 2dimensional 
separation of the originated nucleotides revealed after 
autoradiography 5 major spots (fig.3). Four of these 
spots comigrate with the four 2’(3’)-nucleotide mono- 
phosphates. The material in the remaining spot was 
eluted and counted, thereafter it was digested by alka- 
line-phosphatase, resulting in the production of Pi 
and a product comigrating with the optical marker 
m7GpppAOH (not shown). These results stongly jndi- 
cate that the material from this last spot originates 
from the 5’-terminal cap structure of both 26 S and 
42 S mRNA. In order to calculate the molar ratio of 
cap structure and 26 S or 42 S mRNA, we counted 
the total radioactivity present in the starting material 
and in the ‘cap’ containing spot. The results are sum- 
marized in fig.3. We find that both polysoma126 S 
and viral 42 S mRNA are fully capped (see section 3.4). 
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